A Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung Cancer

Authors:

Abstract
No abstract available
Funding Information
  • Merck Sharp and Dohme United Kingdom
  • Merck & Co Inc

This publication has 35 references indexed in Scilit: